Novavax Announces Initial Omicron Cross-Reactivity Data from C...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
GAITHERSBURG, Md., Dec. 23, 2021 /PRNewswire-AsiaNet/ -- - Two-dose primary regimen of NVX-CoV2373 demonstrated cross-reactive immune responses against Omicron (B.1.1.529) and other variants- Third dose produced increased immune responses comparable to or exceeding levels associated with protection ...
Authors: LATEST ASIANET NEWS RELEASES